Danaher is a diversified conglomerate that develops, manufactures, and sells equipment, consumables, software, and services across three main segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment serves companies developing biological medicines through tools and services for research, manufacturing, and delivery of treatments including monoclonal antibodies, recombinant proteins, and cell and gene therapies; the Life Sciences segment provides instruments and consumables for studying disease-related molecules and cells, along with contamination-removal products; and the Diagnostics segment delivers clinical instruments and services for disease diagnosis and treatment decisions. The company serves pharmaceutical companies, contract manufacturers, hospitals, clinical laboratories, biotechnology firms, academic institutions, and healthcare providers worldwide, generating revenue through product sales, service arrangements, software subscriptions, and technology licensing, with a diversified customer base spanning developed and high-growth markets.